Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
Dec. 27, 2014 segments	Dec. 28, 2013	Dec. 27, 2014	Dec. 28, 2013	Jun. 28, 2014
Segment Reporting Information [Line Items]
Number of Reportable Segments	5us-gaap_NumberOfReportableSegments
Net sales	$ 1,071.7us-gaap_SalesRevenueNet	$ 979.0us-gaap_SalesRevenueNet	$ 2,023.1us-gaap_SalesRevenueNet	$ 1,912.4us-gaap_SalesRevenueNet
Operating Income (Loss)	184.4us-gaap_OperatingIncomeLoss	86.6us-gaap_OperatingIncomeLoss	321.5us-gaap_OperatingIncomeLoss	266.2us-gaap_OperatingIncomeLoss
Intangible assets amortization expense	107.6us-gaap_AmortizationOfIntangibleAssets	43.8us-gaap_AmortizationOfIntangibleAssets	214.2us-gaap_AmortizationOfIntangibleAssets	73.6us-gaap_AmortizationOfIntangibleAssets
Total Assets	16,460.7us-gaap_Assets	13,712.8us-gaap_Assets	16,460.7us-gaap_Assets	13,712.8us-gaap_Assets	13,880.2us-gaap_Assets
Consumer Healthcare [Member]
Segment Reporting Information [Line Items]
Net sales	529.6	536.3	1,022.9	1,074.8
Operating Income (Loss)	74.9	89.5	140.2	179.5
Intangible assets amortization expense	8.7	5.3	17.4	10.6
Total Assets	6,310.9	2,345.5	6,310.9	2,345.5
Nutritionals [Member]
Segment Reporting Information [Line Items]
Net sales	130.6	139.7	255.8	268.7
Operating Income (Loss)	7.2	13.3	15.7	21.0
Intangible assets amortization expense	7.2	7.4	14.4	14.7
Total Assets	1,057.2	1,014.0	1,057.2	1,014.0
Rx Pharmaceuticals [Member]
Segment Reporting Information [Line Items]
Net sales	276.6	246.6	471.2	450.2
Operating Income (Loss)	109.7	100.4	174.4	183.5
Intangible assets amortization expense	18.0	21.5	35.0	37.7
Total Assets	2,612.9	1,940.1	2,612.9	1,940.1
API [Member]
Segment Reporting Information [Line Items]
Net sales	30.0	30.0	54.8	73.2
Operating Income (Loss)	7.4	8.2	14.4	30.6
Intangible assets amortization expense	0.5	0.5	1.0	1.0
Total Assets	255.2	284.7	255.2	284.7
Specialty Sciences [Member]
Segment Reporting Information [Line Items]
Net sales	86.6	7.4	178.4	7.4
Operating Income (Loss)	9.5	(19.0)	24.4	(19.0)
Intangible assets amortization expense	72.8	8.7	145.6	8.7
Total Assets	6,135.6	8,023.8	6,135.6	8,023.8
Other Segments [Member]
Segment Reporting Information [Line Items]
Net sales	18.3	19.0	40.0	38.1
Operating Income (Loss)	1.1	0.6	2.0	1.8
Intangible assets amortization expense	0.4	0.4	0.8	0.9
Total Assets	88.9	104.7	88.9	104.7
Segment Reconciling Items [Member]
Segment Reporting Information [Line Items]
Net sales	0	0	0	0
Operating Income (Loss)	(25.4)	(106.4)	(49.6)	(131.2)
Intangible assets amortization expense	0	0	0	0
Total Assets	$ 0	$ 0	$ 0	$ 0

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name:	us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name:	us-gaap_Assets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

No definition available.

+ Details

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name:	us-gaap_OperatingIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_SegmentReportingInformationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_ApiMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerHealthcareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_NutritionalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_RxPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_SpecialtySciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_MaterialReconcilingItemsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: